Literature DB >> 8656224

Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community.

P A Fall1, O Axelson, M Fredriksson, G Hansson, B Lindvall, J E Olsson, A K Granérus.   

Abstract

Parkinson's disease (PD) shows a geographical variation. All prescriptions for anti-parkinsonian drugs were recorded for a half-year in a region with low L-dopa consumption. Hospital and outpatient records were studied and physicians were asked to supply details of PD patients in the region, with 147,777 inhabitants. The crude prevalence was 115 PD per 100,000 inhabitants, based on 170 cases. In contrast to other studies we report an age-standardized prevalence, which was 76 per 100,000, using the European Standard Population as reference. The corresponding approximate incidences were 11.0 (crude) and 7.9 (age-standardized) per 100,000 person-years. Male preponderance appeared in all age groups. Mean age at onset was 65.6 years, the highest figure reported. Variation between studies for age at onset, differences in prevalence, and male preponderance suggest environmental risk factors to be of importance for PD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656224     DOI: 10.1016/0895-4356(96)00003-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease.

Authors:  S Ylönen; P Ylikotila; A Siitonen; S Finnilä; J Autere; K Majamaa
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

Review 2.  Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.

Authors:  Jerome A Roth
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

3.  Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.

Authors:  Thanh G N Ton; Mary Lou Biggs; Diane Comer; Lesley Curtis; Shu-Ching Hu; Evan L Thacker; Susan Searles Nielsen; Joseph A Delaney; Douglas Landsittel; William T Longstreth; Harvey Checkoway; Samay Jain
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-12-13       Impact factor: 2.890

Review 4.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

5.  Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.

Authors:  K J Schweitzer; S Behnke; I Liepelt; B Wolf; C Grosser; J Godau; A Gaenslen; T Bruessel; A Wendt; F Abel; A Müller; T Gasser; D Berg
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

6.  Impact of psychiatric disorders on Parkinson's disease : a nationwide follow-up study from Sweden.

Authors:  Xinjun Li; Jan Sundquist; Helen Hwang; Kristina Sundquist
Journal:  J Neurol       Date:  2007-12-19       Impact factor: 4.849

7.  The decision-making process leading to deep brain stimulation in men and women with parkinson's disease - an interview study.

Authors:  Katarina Hamberg; Gun-Marie Hariz
Journal:  BMC Neurol       Date:  2014-04-25       Impact factor: 2.474

8.  National surveys: a way to manage treatment strategies in Parkinson's disease? Pharmaceutical prescribing patterns and patient experiences of symptom control and their impact on disease.

Authors:  Orjan Skogar; Mats Nilsson; Carl-Johan Törnhage; Johan Lökk
Journal:  J Multidiscip Healthc       Date:  2013-07-03

Review 9.  Systematic review of the prevalence and incidence of Parkinson's disease in Asia.

Authors:  Weerasak Muangpaisan; Hiroyuki Hori; Carol Brayne
Journal:  J Epidemiol       Date:  2009-10-03       Impact factor: 3.211

Review 10.  Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Authors:  Uduak Williams; Oliver Bandmann; Richard Walker
Journal:  J Mov Disord       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.